PIPELINE PED-425-12Recalls & reported problems
Micro Therapeutics, Inc. · PED-425-12 PIPELINE FLEX 4.25MM X 12MM · Class 3 · Implant
All models of PIPELINE (114)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00847536016088), received between Nov 27, 2019 and Nov 17, 2021 — classified as 2 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
12 other recalls cover devices cleared under the same FDA submission (P100018); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Break2
- Activation Failure1
- Activation, Positioning or Separation Problem1
- Adverse Event Without Identified Device or Use Problem1
- Detachment of Device or Device Component1
- No Apparent Adverse Event1
- Positioning Failure1
- Retraction Problem1
Patient problems
- Device Embedded In Tissue or Plaque1
- Insufficient Information1
- No Clinical Signs, Symptoms or Conditions1
- No Known Impact Or Consequence To Patient1
- Therapeutic Response, Decreased1
- Thrombosis/Thrombus1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 17, 2021Retraction Problem; Retraction Problem
MEDTRONIC RECEIVED A REPORT THAT THE PIPELINE DELIVERY SYSTEM BECAME STUCK IN THE PHENOM MICROCATHETER DURING RETRACTION. THE PATIENT WAS UNDERGOING TREATMENT FOR UNRUPTURED, SACCULAR ANEURYSM LOCATED IN THE OPHTHALMIC SEGMENT OF THE LEFT ICA. THE MAX DIAMETER WAS 6MM, AND THE NECK DIAMETER WAS 4MM. THE PATIENT'S VESSEL TORTUOSITY WAS MODERATE. THE LANDING ZONE WAS 3.2MM DISTAL AND 4.2MM PROXIMAL. THE ACCESS VESSEL WAS THE LEFT ICA, WHICH WAS 4.2MM IN DIAMETER. DUAL ANTIPLATELET TREATMENT WAS ADMINISTERED, AND THE PRU LEVEL WAS 26. IT WAS REPORTED THAT THE PIPELINE WAS SUCCESSFULLY DEPLOYED ACROSS THE ANEURYSM. THE PHYSICIAN WENT THROUGH THE DEVICE TO CAPTURE THE DISTAL PIPELINE WIRE. RETRIEVAL WAS TOUGH, AND THE WIRE BECAME STUCK IN THE CATHETER. THE WIRE AND CATHETER WERE REMOVED, AND THE PATIENT DID NOT EXPERIENCE ANY INJURY OR COMPLICATIONS. THE PUSHWIRE WAS NOT ROTATED DURING REMOVAL, AND THERE WAS NO DAMAGE TO THE CATHETER. ANGIOGRAPHIC RESULTS POST PROCEDURE SHOWED GOOD PLACEMENT. THE PATIENT WOKE UP WITHOUT INCIDENT AND RETURNED TO BASELINE. THE DEVICES WERE PREPARED AND FLUSHED ACCORDING TO THE INSTRUCTIONS FOR USE (IFU). ANCILLARY DEVICES INCLUDE A NAVIEN 072 GUIDE CATHET
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12833170 ↗MalfunctionSep 29, 2021No Apparent Adverse Event; No Apparent Adverse Event
MEDTRONIC RECEIVED A REPORT THAT THE ONE PIPELINE EXPERIENCED RESISTANCE IN THE HUB OF THE PHENOM 27 MICROCATHETER, TWO PIPELINES DEPLOYED IN THE CATHETER HUB, AND A THIRD FAILED TO OPEN DISTALLY AND BROKE DURING RETRIEVAL. THE PATIENT WAS UNDERGOING FLOW DIVERSION TREATMENT FOR AN UNRUPTURED, SACCULAR ANEURYSM LOCATED IN THE LEFT ICA. THE MAX DIAMETER WAS 2.9MM, AND THE NECK DIAMETER WAS 1.5MM. THE PATIENT'S VESSEL TORTUOSITY WAS NORMAL. THE LANDING ZONE WAS WAS 3.5MM DISTAL AND 4.5MM PROXIMAL. THE ACCESS VESSEL WAS THE LEFT ICA, WHICH WAS 3.5-4.5MM IN DIAMETER. IT WAS REPORTED THAT THE FIRST PIPELINE WAS INSERTED INTO THE FIRST PHENOM 27 CATHETER AND DEPLOYED IN THE HUB DURING INSERTION. THE DEVICE WAS REMOVED. A SECOND PIPELINE WAS INSERTED INTO THE CATHETER WITH EXTRA PRECAUTION. THIS DEVICE HAD RESISTANCE IN THE CATHETER HUB AND ALSO DEPLOYED IN HUB. THE TIP OF THE SHEATH HAD BEEN SEATED SECURELY IN THE HUB. THE SECOND PIPELINE WAS REMOVED ALONG WITH PHENOM 27 CATHETER WHICH WAS REPLACED WITH A NEW PHENOM 27. A THIRD PIPELINE WAS INSERTED INTO THE CATHETER AND WAS ABLE TO BE INTRODUCED INTO CATHETER. DURING DEPLOYMENT OF THIS PIPELINE, THE DEVICE WOULD NOT OPEN DISTALLY AND HA
Patient problems: Insufficient Information
MAUDE report 12550180 ↗MalfunctionJun 3, 2021Activation Failure; Activation Failure
ADDITIONAL INFORMATION RECEIVED REPORTED THAT THE PROCEDURE WAS NOT COMPLETED. AT THIS TIME, THERE WAS NOT A PROCEDURE PLAN CHANGE AS WELL AS THERE WAS NO ADDITIONAL INTERVENTION FOR TREATMENT OF THE PATIENT'S ANEURYSM PLANNED FOR THE FUTURE. THE PATIENT WAS CURRENTLY ASYMPTOMATIC.
Patient problems: Thrombosis/Thrombus
MAUDE report 11931902 ↗MalfunctionMar 31, 2020Break; Positioning Failure; Activation, Positioning or Separation Problem; Break; Positioning Failure; Activation, Positioning or Separation Problem
IT WAS REPORTED THAT THE PREVIOUS PIPELINE (PLI20) IMPLANTED ONE YEAR PRIOR SHOWED RESIDUAL ANEURYSM. A NEW PIPELINE (PLI10) WAS IMPLANTED, BUT EXPERIENCED RESISTANCE DURING DELIVERY. THE NEW PIPELINE WAS SUCCESSFULLY DELIVERED WITH A SLIGHT INCOMPLETE APPOSITION OF THE DISTAL SEGMENT. IT WAS INDICATED THERE WAS DIFFICULT PLACEMENT/POSITIONING. A SYNCHRO 14 WIRE WITH A J-CURVE WAS ADVANCED TO THE DISTAL SEGMENT OF THE PIPELINE, AND THE TIP OF THE WIRE APPEARED INSIDE THE MARKSMAN MICROCATHETER. THE MARKSMAN WAS REMOVED FROM THE PATIENT AND FLUSHED ON THE TABLE REVEALING THE DISTAL TIP OF THE WIRE HAD FRACTURED AT THE JUNCTION ON THE WELD JOINT. A MICROVENTION SEPTER C BALLOON WAS ADVANCED AND DILATED WHICH SUCCESSFULLY COMPLETED APPOSITION OF THEDISTAL SEGMENT OF THE PIPELINE. IT WAS INDICATED THAT ALL DEVICES WERE PREPARED AS PER THE INSTRUCTIONS FOR USE (IFU), AND NO PATIENT SYMPTOMS OR FURTHER COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. ANCILLARY DEVICES INCLUDE A PHENOM MICROCATHETER, MARKSMAN MICROCATHETER, FUBUKI SHEATH, MICROVENTION BALLOON, SYNCHRO 14 GUIDEWIRE. ADDITIONAL INFORMATION: THE PREVIOUSLY IMPLANTED PIPELINE MODEL AND LOT NUMBERS ARE (INITIAL TREATMENT
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9903499 ↗InjuryJan 13, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
MEDTRONIC RECEIVED REPORT THAT THE PATIENT WAS REPORTED TO HAVE BEEN TREATED FOR A POST TRAUMATIC AUTOMOBILE ACCIDENT THAT RESULTED IN A LEFT, PROXIMAL, INTERNAL CAROTID ARTERY (ICA) PSEUDOANEURYSM /FISTULA. THE PATIENT WAS INITIALLY TREATED WITH 2 FLOW DIVERTER. HOWEVER, SINCE THE BLOOD FLOW WAS STILL PRESENT THE PATIENT UNDERWENT A SECOND PIPELINE PROCEDURE ON (B)(6) 2019 AND A 3RD PIPELINE WAS IMPLANTED.
Patient problems: Therapeutic Response, Decreased
MAUDE report 9580329 ↗InjuryNov 27, 2019Break; Detachment of Device or Device Component; Break; Detachment of Device or Device Component
MEDTRONIC RECEIVED A REPORT OF PIPELINE FLEX PUSHWIRE SEPARATION DURING A PROCEDURE. THE PATIENT WAS UNDERGOING TREATMENT OF A LEFT ICA, UNRUPTURED, SACCULAR ANEURYSM. THE DISTAL LANDING ZONE WAS 3.7MM AND THE PROXIMAL WAS 4.1MM. THE VESSEL TORTUOSITY WAS MINIMAL. THE DEVICES WERE PREPARED AND USED PER THE INSTRUCTIONS FOR USE (IFU). THE CATHETER WAS FLUSHED PER THE IFU. THE PIPELINE FLEX BRAID WAS DEPLOYED WITHOUT ISSUE. DURING RECAPTURE OF THE DELIVERY SYSTEM, THE PROXIMAL BUMPER WAS POSITIONED CLOSE TO THE POSTERIOR GENU AND AS THE MICROCATHETER WAS ADVANCED, THERE WAS A NOTED SEPARATION OF THE DELIVERY WIRE AT THE PROXIMAL BUMPER. WHEN THIS WAS NOTED, THE PROXIMAL SECTION OF THE DELIVERY WIRE WAS REMOVED, LEAVING THE DISTAL PORTION IN THE VESSEL. ATTEMPTS WERE MADE TO CAPTURE THE DISTAL WIRE WITH SEVERAL SNARES WITHOUT SUCCESS. THE FINAL DECISION WAS TO DEPLOY TWO STENTS ACROSS THE ENTIRE LENGTH OF THE FREE WIRE.
Patient problems: Device Embedded In Tissue or Plaque
MAUDE report 9386354 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P100018. One submission often covers many models, so check the product and lot details in each record.
- Z-1245-2025 · Jan 30, 2025 · Open, ClassifiedMedtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-027-350-12, PED3-027-350-14, PED3-027-350-16, PED3-027-350-20, PED3-027-350-25, PED3-027-400-12, PE
- Z-1246-2025 · Jan 30, 2025 · Open, ClassifiedMedtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-021-350-16, PED3-021-250-14, PED3-021-350-20, PED3-021-250-20, PED3-021-300-16, PED3-021-300-20, PE
- Z-2403-2021 · Jul 13, 2021 · Open, ClassifiedEV3 Pipeline Flex Embolization Device with Flex Shield Technology
- Z-2402-2021 · Jul 13, 2021 · Open, ClassifiedPipeline Flex Embolization Device
- Z-1527-2020 · Feb 14, 2020 · Terminatedev3 Pipeline Flex Embolization Device. For neurological endovascular use.
- Z-0308-2017 · Oct 5, 2016 · TerminatedAlligator Retrieval Device The device is intended for use in the peripheral and neurovasculature for foreign body removal. Catalog No. FA-88810-20V04 FA-88810-20V06 FA-88810-30V04
- Z-0309-2017 · Oct 5, 2016 · TerminatedMarathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled
- Z-0307-2017 · Oct 5, 2016 · TerminatedPipeline Embolization Device (Pipeline Classic) The device is indicated for the endovascular treatment of adults (22 year of age or older) with large or giant widenecked intracrani
- Z-0310-2017 · Oct 5, 2016 · TerminatedX-Celerator Hydrophilic Exchange Guidewire Catalog No. 103-0601-300 103-0601-350V10 103-0602-350V06 103-0601-300V01 103-0602-300 103-0602-350V09 103-0601-300V02 103-0602-300V01 10
- Z-0120-2016 · Sep 4, 2015 · Terminated-Pipeline Embolization Device -Pipeline Flex Embolization Device The Pipeline and Pipeline Flex Embolization Devices consist of a permanent implant combined with a guidewire based
- Z-1453-2014 · Apr 1, 2014 · TerminatedPipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the internal carotid artery.
- Z-2045-2013 · Jul 19, 2013 · TerminatedPipeline Embolization Device (PED) The Pipeline Embolization Device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide-neck
Other Intracranial aneurysm flow diverter devices
- Pipeline TM Flex Embolization Device with Shield Technology TM PED2-300-12Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter2 recalls1 report
- PIPELINE PED-500-20Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall31 reports
- PIPELINE PED-500-35Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death29 reports
- PIPELINE PED-500-16Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall2 deaths27 reports
- PIPELINE PED-500-25Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death23 reports
- PIPELINE PED-500-30Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall21 reports
- PIPELINE PED-450-25Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall20 reports
- PIPELINE PED-475-30Micro Therapeutics, Inc. · Intracranial aneurysm flow diverter1 recall1 death19 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page